Transgene has announced the launch of Invir.IO, a new platform to help the design of new oncolytic viruses that modulate the cancer microenvironment. Transgene designs targeted immunotherapies for the treatment of cancer and infectious diseases. Their lead products include Pexa-Vec, an oncolytic …

This awesome article French Biotech Launches Tech Platform to Boost New Cancer Treatment Research appeared first on Labiotech.eu. Be kind and don’t copy it without asking 😉



Source link